Quant-iT™ microRNA Assay Kit
Use 96- and 384-well Microplates for Fluorescence-based Assays with Quant-iT assays for optimal results
Quant-iT™ microRNA Assay Kit
Invitrogen™

Quant-iT™ microRNA Assay Kit

Quantitate microRNA easily and accurately with the Quant-iT microRNA Assay Kit, a microRNA (miRNA) detection kit that detects miRNA even자세히 알아보기
Have Questions?
카탈로그 번호수량
Q328821 kit
카탈로그 번호 Q32882
제품 가격(KRW)
924,000
Online offer
Ends: 31-Dec-2025
1,086,000
할인액 162,000 (15%)
Each
카트에 추가하기
수량:
1 kit
제품 가격(KRW)
924,000
Online offer
Ends: 31-Dec-2025
1,086,000
할인액 162,000 (15%)
Each
카트에 추가하기
Quantitate microRNA easily and accurately with the Quant-iT microRNA Assay Kit, a microRNA (miRNA) detection kit that detects miRNA even in the presence of common contaminants such as salts, free nucleotides, solvents, detergents, and protein. The assay is highly selective for microRNA over rRNA or large mRNA (>1000 bp).

Although not exclusively selective for miRNA, the assay reagent can reproducibly quantify miRNA in pure samples down to levels as low as 0.5 ng following the supplied protocol, even in the presence of mRNA.

Features of the Quant-iT microRNA Assay Kit include:
• Sensitive detection of as little as 0.5 ng miRNA in a microplate well.
• A core dynamic range of 5–500 ng/mL.
• Accurate readings of sample concentrations ranging from 50 ng/mL to 100 μg/mL.

The Quant-iT microRNA Assay Kit provides concentrated assay reagent, dilution buffer, and pre-diluted miRNA standards. Simply dilute the reagent 1:200, load 200 μL into the wells of a microplate, add 1–20 μL of sample, mix, and read the fluorescence. The assay is performed at room temperature, and the signal is stable for approximately three hours. Because the assay tolerates 1–20 μL of sample in an assay volume of 200 μL, accurate results can be obtained for initial sample concentrations from 50 ng/mL–100 μg/mL.
For Research Use Only. Not for use in diagnostic procedures.
사양
어세이microRNA Quantitation
여기/방출498/518
용도(장비)Fluorometer, Microplate Reader
반응 수1000 x 200 μL assays
제품라인Quant-iT
정량 범위1 to 100 ng
수량1 kit
검출 방법Fluorescence
Unit SizeEach

자주 묻는 질문(FAQ)

Why am I getting negative fluorescence values with my Qubit Assays?

Negative fluorescence is a physical impossibility. It is an artifact from software autocorrecting for background signal. This means your reader is picking up and subtracting out background light at the cost of your data. Make sure to do a buffer-only control and assess the type of signal. You may need to switch to a different plate.

인용 및 참조 문헌 (5)

인용 및 참조 문헌
Abstract
MicroRNA detection based on duplex-specific nuclease-assisted target recycling and gold nanoparticle/graphene oxide nanocomposite-mediated electrocatalytic amplification.
Authors:Han Y, Qiu Z, Nawale GN, Varghese OP, Hilborn J, Tian B, Leifer K
Journal:Biosens Bioelectron
PubMed ID:30611105
DNA technology based bio-responsive nanomaterials have been widely studied as promising tools for biomedical applications. Gold nanoparticles (AuNPs) and graphene oxide (GO) sheets are representative zero- and two-dimensional nanomaterials that have long been combined with DNA technology for point-of-care diagnostics. Herein, a cascade amplification system based on duplex-specific nuclease (DSN)-assisted ... More
A universal fluorescence-based toolkit for real-time quantification of DNA and RNA nuclease activity.
Authors:Sheppard EC, Rogers S, Harmer NJ, Chahwan R
Journal:Sci Rep
PubMed ID:31222049
DNA and RNA nucleases play a critical role in a growing number of cellular processes ranging from DNA repair to immune surveillance. Nevertheless, many nucleases have unknown or poorly characterized activities. Elucidating nuclease substrate specificities and co-factors can support a more definitive understanding of cellular mechanisms in physiology and disease. ... More
Differences in the miRNA signatures of chronic musculoskeletal pain patients from neuropathic or nociceptive origins.
Authors:Dayer CF, Luthi F, Le Carré J, Vuistiner P, Terrier P, Benaim C, Giacobino JP, Léger B
Journal:PLoS One
PubMed ID:31276478
The quality of life for millions of people worldwide is affected by chronic pain. In addition to the effect of chronic pain on well-being, chronic pain has also been associated with poor health conditions and increased mortality. Due to its multifactorial origin, the classification of pain types remains challenging. MicroRNAs ... More
Multifunctional hybrid nanoparticles as magnetic delivery systems for siRNA targeting the HER2 gene in breast cancer cells.
Authors:Cristofolini T, Dalmina M, Sierra JA, Silva AH, Pasa AA, Pittella F, Creczynski-Pasa TB
Journal:Mater Sci Eng C Mater Biol Appl
PubMed ID:32228895
Breast cancer is a major cause of death among women worldwide. Resistance to conventional therapies has been observed in HER2-positive breast cancer patients, indicating the need for more effective treatments. Small interfering RNA (siRNA) therapy is an attractive strategy against HER2-positive tumors, but its success depends largely on the efficient ... More
Identification and Validation of MicroRNA Profiles in Fecal Samples for Detection of Colorectal Cancer.
Authors:Duran-Sanchon S, Moreno L, Augé JM, Serra-Burriel M, Cuatrecasas M, Moreira L, Martín A, Serradesanferm A, Pozo À, Costa R, Lacy A, Pellisé M, Lozano JJ, Gironella M, Castells A
Journal:Gastroenterology
PubMed ID:31622624
Screening for colorectal cancer (CRC) is effective in the population at average risk. The most extended strategy in organized programs involves the fecal immunochemical test, which is limited by low sensitivity for the detection of advanced adenomas (AAs). We aimed to identify microRNA (miRNA) signatures in fecal samples that identify ... More